US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.54

-0.3850-2.03%

Post-market: 18.540.00000.00%19:30 EDT

Volume:64.75K

Turnover:1.20M

Market Cap:107.55M

PE:- -

High:18.87

Open:18.87

Low:18.44

Close:18.93

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:2.51

T/O Rate:1.12%

Dividend:0.71

Dividend Rate:3.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharma Begins Trial for Weight Management Drug in China

MT Newswires Live

CSPC Pharma Advances Weight Management Pipeline With Phase 1 Trial Kickoff

CSPC Pharma Wins China NMPA Clearance to Start Phase 1 Trial of Syh2092 Obesity Drug

CSPC Pharmaceutical - Initiates Phase I Clinical Trial of Syh2092 Injection for Weight Management in China

THOMSON REUTERS

Wuxi Biologics (Cayman) Stock Slips 3.6% in Hong Kong

CSPC Pharmaceutical Group Stock Sheds 3.0% in Hong Kong, Underperforms Competitors

WuXi Biologics' Stronger Project Backlog Could Underpin Revenue Visibility

Akeso, Inc. (HKG:9926) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

WuXi XDC Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 1,707,842 Shares

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

China's Joinn Laboratories H1 Profit Jumps 1,127% on Strong Drug Demand

Hong Kong's Frontage Holdings H1 Profit More than Doubles on Teddy Lab Acquisition

CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint

Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's

CMB International Lifts WUXI BIO Price Target to HK$60, Maintains "Buy" Rating

Akeso's Losses Narrow in H1 as Revenue Climbs 28%

MT Newswires Live

Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.

Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares

Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/KURE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.54,"timestamp":1788206400000,"preClose":18.925,"halted":0,"volume":64746,"hourTrading":{"tag":"盘后","latestPrice":18.54,"preClose":18.54,"latestTime":"19:30 EDT","volume":10,"amount":185.4,"timestamp":1788219002391,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.020343461030383172,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Closed","change":-0.385,"latestTime":"08-31 16:00:00 EDT","open":18.87,"high":18.87,"low":18.44,"amount":1197156.0003479999,"amplitude":0.022721,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.925,"sharesOutstanding":4750002,"nav":19,"aum":110211439.71,"dividendRate":0.038554,"bidAskSpread":0.005823,"postHourTrading":{"tag":"盘后","latestPrice":18.54,"preClose":18.54,"latestTime":"19:30 EDT","volume":10,"amount":185.4,"timestamp":1788219002391,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.508893,"impliedVol":0.2767,"impliedVolPercentile":0.5737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.508893,"shares":5800979,"dividePrice":0.7148,"high":18.87,"amplitude":0.022721,"preClose":18.925,"low":18.44,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.54,"eps":0,"divideRate":0.038554,"volume":64746,"delay":0,"ttmEps":0,"open":18.87,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":17.28,"prevQuarterClose":15.747,"fiveDayClose":18.6163,"twentyDayClose":17.0849,"sixtyDayClose":15.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663003385","title":"CSPC Pharma Begins Trial for Weight Management Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003385?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:22","pubTimestamp":1788178969,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) officially began a phase I clinical trial of the SYH2092 injection at the first center in China.The drug has been developed for weight management in adult patients with obesity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","IE0008368742.USD","BK1521","LU1226287792.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1226288253.USD","HK0000165453.HKD","LU1226288170.HKD","LU1226287529.USD","IE00B031HY20.USD","IE0008369823.USD","LU0067412154.USD","IE00BZ08YS42.EUR","BK1515","LU1152091754.HKD","LU0501845795.SGD","SG9999004220.SGD","LU0140636845.USD","KURE","LU0314109678.HKD","LU1813983027.USD","01093","BK1191","LU1951186391.HKD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1328277881.USD","LU0315179316.USD","LU0072913022.USD","IE00B543WZ88.USD","LU1960683339.HKD","LU1226287875.USD","LU1993786604.SGD","LU1807302812.USD","LU0880133367.SGD","LU1008478684.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178504231","title":"CSPC Pharma Advances Weight Management Pipeline With Phase 1 Trial Kickoff","url":"https://stock-news.laohu8.com/highlight/detail?id=1178504231","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178504231?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177626,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced the official initiation of the first clinical trial site in China for its Phase 1 study of the SYH2092 injection, targeting weight management in adults who are...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU0315179316.USD","LU0501845795.SGD","LU1008478684.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","LU1152091168.USD","IE00B5MMRT66.SGD","IBBQ","PSYK","LU1226288170.HKD","LU1813983027.USD","LU1226288253.USD","IBBJ","LU1152091754.HKD","HK0000165453.HKD","BK1515","LU0140636845.USD","LU0314109678.HKD","01093","LU1226287792.SGD","LU1993786604.SGD","MDTX","LU1951186391.HKD","LU0072913022.USD","BK1521","LU2039709279.SGD","IE00B543WZ88.USD","BMED","LU0326950275.SGD","LU1807302812.USD","LU0067412154.USD","IE00B031HY20.USD","IE0008368742.USD","LU1226287875.USD","LU1328277881.USD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1226287529.USD","KURE","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008868","title":"CSPC Pharma Wins China NMPA Clearance to Start Phase 1 Trial of Syh2092 Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008868","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008868?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:53","pubTimestamp":1788177190,"startTime":"0","endTime":"0","summary":"CSPC Pharma wins China NMPA clearance to start Phase 1 trial of SYH2092 obesity drugCSPC received China NMPA clearance in August 2026 to start clinical trials of SYH2092 for weight management in overw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLnjzPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","IE00B543WZ88.USD","LU1226288170.HKD","LU0072913022.USD","LU1993786604.SGD","LU0314109678.HKD","KURE","IE00B5MMRT66.SGD","LU1807302812.USD","HK0000165453.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1328277881.USD","SG9999004220.SGD","LU0140636845.USD","LU0315179316.USD","IE0008369823.USD","BK1521","BK1515","IE0008368742.USD","LU1152091168.USD","LU1226287529.USD","LU1008478684.HKD","LU2039709279.SGD","LU0067412154.USD","LU0501845795.SGD","LU1226287792.SGD","LU1951186391.HKD","LU1813983027.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1152091754.HKD","LU1226287875.USD","IE00BZ08YS42.EUR","BK1191","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663882008","title":"CSPC Pharmaceutical - Initiates Phase I Clinical Trial of Syh2092 Injection for Weight Management in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2663882008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663882008?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:52","pubTimestamp":1788177157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S098:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","LU1226287875.USD","BK1191","LU1226288170.HKD","01093","LU1226287529.USD","LU1226287792.SGD","LU1152091168.USD","LU0140636845.USD","HK0000165453.HKD","IE0008369823.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1328277881.USD","IE0008368742.USD","LU1993786604.SGD","LU1960683339.HKD","LU0880133367.SGD","LU0501845795.SGD","LU1807302812.USD","LU0072913022.USD","LU1951186391.HKD","LU0314109678.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU0326950275.SGD","KURE","LU2039709279.SGD","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","LU0315179316.USD","IE00B031HY20.USD","LU1008478684.HKD","LU0067412154.USD","BK1521","LU1226288253.USD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073052","title":"Wuxi Biologics (Cayman) Stock Slips 3.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073052?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:32","pubTimestamp":1788165120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 3.6% to 48.84 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.Wuxi Biologics  Inc. closed 10% below its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 47.4 million shares, compared to the 50-day average of 37.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0320764599.SGD","LU1242518931.SGD","LU0181495838.USD","LU0456827905.SGD","LU0326950275.SGD","LU0348735423.USD","LU0327786744.USD","LU0588546209.SGD","LU0823426308.USD","SG9999002463.SGD","LU0856984785.SGD","LU1688375341.USD","LU0572944931.SGD","LU0128526141.USD","LU0417516738.SGD","BK1589","LU0516422440.USD","LU0359201612.USD","LU0516423174.USD","LU1720050803.USD","LU0979878070.USD","LU2039709279.SGD","LU0708995583.HKD","LU0140636845.USD","KURE","LU0823426480.USD","02269","LU1794554557.SGD","LU0348825331.USD","LU0307460666.USD","LU1880383366.USD","LU0516423091.SGD","LU3063872942.SGD","LU0043850808.USD","LU0516422952.EUR","LU0039217434.USD","BK1610","LU0516422366.SGD","LU0052750758.USD","LU0029874061.USD","LU1242518857.USD","BK1576","LU0456846285.SGD","LU0051755006.USD","LU0819121731.USD","LU0417516902.SGD","IE00B0JY6N72.USD","BK1521","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073038","title":"CSPC Pharmaceutical Group Stock Sheds 3.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073038?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:32","pubTimestamp":1788165120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 3.0% to 9.24 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 21% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 2.6%, SSY Group Ltd. rose 0.4%, and United Laboratories International Holdings Ltd. fell 3.4%.Trading volume totaled 136.5 million shares, compared to the 50-day average of 104.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","LU0067412154.USD","LU0326950275.SGD","LU1152091754.HKD","LU1008478684.HKD","LU1807302812.USD","LU1960683339.HKD","LU0880133367.SGD","LU0072913022.USD","LU1951186391.HKD","LU0315179316.USD","IE0008369823.USD","LU0314109678.HKD","LU1813983027.USD","LU2039709279.SGD","LU0140636845.USD","LU0501845795.SGD","LU1226287875.USD","KURE","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1328277881.USD","LU1226288253.USD","HK0000165453.HKD","IE00B031HY20.USD","LU1226287792.SGD","LU1152091168.USD","LU1226288170.HKD","BK1191","IE00BZ08YT58.USD","IE0008368742.USD","LU1993786604.SGD","SG9999004220.SGD","01093","BK1521","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663707395","title":"WuXi Biologics' Stronger Project Backlog Could Underpin Revenue Visibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2663707395","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663707395?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:13","pubTimestamp":1788163980,"startTime":"0","endTime":"0","summary":"0813 GMT - WuXi Biologics' stronger project backlog is likely to underpin its revenue visibility, says China Galaxy International Securities' Vicky Zhu in a note. The contract research, development and manufacturing company added 169 new projects and 119 net integrated projects in 1H, while its total revenue backlog reached US$25.1 billion as of end June, she notes. The acquisition of BioDlink also contributed to the higher number of projects, she adds. She raises her 2026-2027 revenue growth estimates to around 21% and lifts her 2026-2028 earnings per share estimates by 2%-8%. China Galaxy therefore raises its target price to HK$57.82 from HK$48.62 and maintains an add rating. Shares closed 3.6% lower at HK$48.84.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU0417516902.SGD","LU0708995583.HKD","LU0043850808.USD","LU1242518931.SGD","LU0823426480.USD","LU1794554557.SGD","LU2039709279.SGD","LU0516422952.EUR","LU0456846285.SGD","LU0320764599.SGD","LU0516423091.SGD","LU1880383366.USD","LU0029874061.USD","LU1720050803.USD","LU0128526141.USD","BK1589","LU0181495838.USD","BK1610","LU0327786744.USD","LU0572944931.SGD","LU0348825331.USD","LU0856984785.SGD","IE00B0JY6N72.USD","LU0140636845.USD","LU0051755006.USD","SG9999002562.SGD","LU0359202008.SGD","LU0359201612.USD","LU0307460666.USD","02269","LU0326950275.SGD","LU0039217434.USD","BK1521","LU0516422440.USD","SG9999002463.SGD","LU0516423174.USD","LU3063872942.SGD","BK1576","LU0823426308.USD","LU0348735423.USD","LU0979878070.USD","BK1141","LU1688375341.USD","LU0516422366.SGD","LU0417516738.SGD","LU0819121731.USD","KURE","LU1242518857.USD","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663228310","title":"Akeso, Inc. (HKG:9926) Analysts Are Cutting Their Estimates: Here's What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2663228310","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663228310?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:40","pubTimestamp":1788140412,"startTime":"0","endTime":"0","summary":"Investors in Akeso, Inc. ( HKG:9926 ) had a good week, as its shares rose 5.7% to close at HK$95.35 following the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-inc-hkg9926-analysts-are-cutting-their-estimates-heres","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-inc-hkg9926-analysts-are-cutting-their-estimates-heres","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09926","LU1961090484.USD","KURE","LU2488822045.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0561508036.HKD","LU2399975544.HKD","LU0348784397.USD","LU0417516571.SGD","LU2476274720.SGD","LU0540923850.HKD","IE00BPRC5H50.USD","LU0634319403.HKD","BK1161","LU0348783233.USD","LU2778985437.USD","LU1720050803.USD","LU0417516738.SGD","LU0348825331.USD","LU1794554557.SGD","BK1574","LU0348827113.USD","LU0348766576.USD","LU2476274308.USD","IE00B543WZ88.USD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662095555","title":"WuXi XDC Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 1,707,842 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662095555","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662095555?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:12","pubTimestamp":1787922773,"startTime":"0","endTime":"0","summary":"WuXi XDC files HKEX next-day disclosure return, lifts share capital by 1,707,842 sharesWuxi XDC filed a next-day disclosure return showing 1,707,842 new ordinary shares issued from share option exerci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLYmvG5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0128526141.USD","LU0348735423.USD","LU2488822045.USD","LU1242518857.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0516422440.USD","SG9999014674.SGD","LU0572944931.SGD","LU0051755006.USD","LU2039709279.SGD","LU0052750758.USD","LU0417516902.SGD","LU1880383366.USD","LU3063872942.SGD","LU0708995583.HKD","LU0320764599.SGD","LU1794554557.SGD","KURE","LU0348825331.USD","BK1576","LU0359201612.USD","LU0823426480.USD","LU0823426308.USD","LU0588546209.SGD","LU0456846285.SGD","LU0181495838.USD","LU0359202008.SGD","BK1610","LU0029874061.USD","LU0039217434.USD","LU0043850808.USD","02268","LU0417516738.SGD","LU0516422952.EUR","LU0856984785.SGD","LU1688375341.USD","LU1242518931.SGD","LU0326950275.SGD","LU0979878070.USD","LU0516423091.SGD","LU0516423174.USD","LU0140636845.USD","LU1720050803.USD","SG9999002463.SGD","BK1141","LU0516422366.SGD","02269","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662172061","title":"China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2662172061","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662172061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:28","pubTimestamp":1787912881,"startTime":"0","endTime":"0","summary":"China's Dawnrays Pharmaceutical H1 revenue falls on lower procurement pricesOverviewChina pharmaceutical maker's interim revenue fell 13.4% yr/yr on lower sales of key productsProfit attributable to o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU2242644610.SGD","LU2097828474.EUR","LU2328871848.SGD","LU2097828714.EUR","LU0455707207.USD","LU0463099449.HKD","BK1606","LU0244354667.USD","BK1583","BK1589","LU2097828631.EUR","LU2488822045.USD","BK1191","LU2097828557.USD","LU1188198961.HKD","KURE","02348","LU0502904849.HKD","03737","LU2097828805.USD","01801","BK1161","LU1969619763.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066488","title":"China's Joinn Laboratories H1 Profit Jumps 1,127% on Strong Drug Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066488","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662066488?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:54","pubTimestamp":1787910858,"startTime":"0","endTime":"0","summary":"China's Joinn Laboratories H1 profit jumps 1,127% on strong drug demandOverviewChina CRO services provider's interim revenue grew 5.3% yr/yr, net income surged 1,126.8%Company attributed growth to mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0B3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","BK0174","LU0327786744.USD","603127","LU0320764599.SGD","LU0039217434.USD","LU0979878070.USD","SG9999002463.SGD","KURE","300347","LU1794554557.SGD","LU0588546209.SGD","LU0140636845.USD","LU0348735423.USD","LU0516422440.USD","LU1688375341.USD","LU1146622755.USD","LU0043850808.USD","BK1589","BK1610","LU0572944931.SGD","LU0708995583.HKD","LU0516422366.SGD","BK0028","LU0029874061.USD","BK1521","LU2039709279.SGD","LU0819121731.USD","LU1720050803.USD","LU0417516738.SGD","02269","BK0077","01873","06127","LU0181495838.USD","LU1880383366.USD","BK0216","LU0052750758.USD","LU3063872942.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU0417516902.SGD","LU0856984785.SGD","LU0359201612.USD","LU0823426308.USD","LU0326950275.SGD","LU0307460666.USD","LU0516422952.EUR","BK1141","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662078065","title":"Hong Kong's Frontage Holdings H1 Profit More than Doubles on Teddy Lab Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662078065","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662078065?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:43","pubTimestamp":1787910206,"startTime":"0","endTime":"0","summary":"Hong Kong's Frontage Holdings H1 profit more than doubles on Teddy Lab acquisitionOverviewHong Kong-based CRO's H1 revenue rose 17% yr/yr to $148.2 mlnNet profit for H1 more than doubled to $6.8 mlnCo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0572944931.SGD","LU0456846285.SGD","LU0516422952.EUR","LU0128526141.USD","BK1521","BK0077","LU0417516738.SGD","KURE","BK0028","LU0348735423.USD","LU0039217434.USD","LU1880383366.USD","LU0307460666.USD","LU0043850808.USD","LU0417516902.SGD","SG9999002463.SGD","LU2039709279.SGD","LU0320764599.SGD","BK0174","BK1610","01521","LU1794554557.SGD","BK1141","BK0216","LU1242518931.SGD","LU0140636845.USD","LU0181495838.USD","LU1146622755.USD","02269","LU0052750758.USD","BK1583","LU0029874061.USD","BK1589","LU0856984785.SGD","LU0326950275.SGD","300347","LU0327786744.USD","LU0823426308.USD","LU1688375341.USD","LU0516422366.SGD","LU3063872942.SGD","LU1720050803.USD","LU0359201612.USD","LU0588546209.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0819121731.USD","LU0979878070.USD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050237","title":"CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050237?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:32","pubTimestamp":1787905920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 1.5% to 9.53 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25584.79.The stock's fall snapped a four-day winning streak.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.7%, SSY Group Ltd. rose 0.4%, and United Laboratories International Holdings Ltd. fell 1.8%.Trading volume totaled 74.5 million shares, compared to the 50-day average of 104.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","BK1515","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","KURE","LU0067412154.USD","LU1226287875.USD","IE0008368742.USD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YT58.USD","BK1191","HK0000165453.HKD","BK1521","LU0314109678.HKD","LU1008478684.HKD","LU0315179316.USD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU2039709279.SGD","LU0072913022.USD","LU0140636845.USD","LU1328277881.USD","LU1226288170.HKD","LU1226287792.SGD","LU1951186391.HKD","IE0008369823.USD","LU1226287529.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","IE00B031HY20.USD","IE00B543WZ88.USD","LU1813983027.USD","LU1152091754.HKD","LU1993786604.SGD","LU0501845795.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662936058","title":"Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662936058","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662936058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:45","pubTimestamp":1787885130,"startTime":"0","endTime":"0","summary":"Akeso says Phase III ivonescimab-chemo trial in biliary tract cancer meets overall survival endpointAkeso highlighted late-stage gains for ivonescimab, with a Phase III first-line biliary tract cancer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6VxC1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU1961090484.USD","LU2476274720.SGD","LU0348783233.USD","LU1720050803.USD","LU0348784397.USD","LU0348735423.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348766576.USD","LU0417516738.SGD","KURE","LU0348825331.USD","LU2399975544.HKD","BK1574","LU2488822045.USD","BK1161","LU0540923850.HKD","LU0348767384.USD","LU2778985437.USD","LU0348827113.USD","LU0634319403.HKD","LU0417516902.SGD","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058969","title":"Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058969?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:45","pubTimestamp":1787885100,"startTime":"0","endTime":"0","summary":"HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) (\"Akeso\" or the \"Company\") announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","BK4512","LU1861214812.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00BFMHRM44.USD","LU0634319403.HKD","LU0417516571.SGD","COAL","BK4585","LU0561508036.HKD","LU2476274720.SGD","CNS","LU2357305700.SGD","KURE","LU0348825331.USD","LU1861220033.SGD","LU1720050803.USD","BK1161","LU0348784397.USD","LU0348723411.USD","LU2778985437.USD","ONG","09926","LU1720051017.SGD","LU1794554557.SGD","LU2298322129.HKD","ON","LU0348735423.USD","BK4135","BK4588","BK4195","BK4211","BK4006","LU1720051108.HKD","IE00BPRC5H50.USD","LU0348766576.USD","BK4141","LU2399975544.HKD","ONX","LU0348827113.USD","HCC","LU1983260115.SGD","LU2360107325.USD","IE00B543WZ88.USD","LU1548497426.USD","LU1861215975.USD","LU1854104046.USD","LU1854103824.USD","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145217194","title":"CMB International Lifts WUXI BIO Price Target to HK$60, Maintains \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1145217194","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145217194?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:44","pubTimestamp":1787885052,"startTime":"0","endTime":"0","summary":"CMB International has released a research report highlighting WUXI BIO (02269)'s strong first-half performance, which prompted an upward revision of its full-year revenue growth guidance to 15%-18%....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0140636845.USD","LU0181495838.USD","LU0039217434.USD","02269","LU0516422952.EUR","SG9999002463.SGD","LU0516423091.SGD","LU1242518931.SGD","LU0029874061.USD","LU0307460666.USD","LU0417516738.SGD","LU0051755006.USD","EWH","LU0823426480.USD","LU0052750758.USD","LU0359202008.SGD","BK1610","LU0320764599.SGD","LU0043850808.USD","LU0856984785.SGD","LU0823426308.USD","LU0348825331.USD","LU0327786744.USD","LU0572944931.SGD","LU0359201612.USD","LU0128526141.USD","LU1242518857.USD","LU1720050803.USD","SG9999002562.SGD","LU1688375341.USD","LU0516422440.USD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0348735423.USD","BK1521","LU0456846285.SGD","LU0516422366.SGD","LU0819121731.USD","KURE","LU2039709279.SGD","BK1141","BK1576","BK1589","LU0708995583.HKD","LU0326950275.SGD","LU0456827905.SGD","LU1794554557.SGD","LU3063872942.SGD","LU0979878070.USD","LU0417516902.SGD","LU1880383366.USD","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203452","title":"Akeso's Losses Narrow in H1 as Revenue Climbs 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203452","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203452?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:06","pubTimestamp":1787875618,"startTime":"0","endTime":"0","summary":"Akeso  reported an attributable loss of 424.2 million yuan for the first half, narrowing from a loss of 570.1 million a year earlier.Loss per share stood at 0.46 yuan, compared with 0.64 yuan in the year-ago period, according to a Thursday filing with the Hong Kong Exchange.The biotech company's revenue increased 28% year over year to 1.81 billion yuan for the six months ended June 30 from 1.41 billion yuan.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348766576.USD","LU1961090484.USD","BK1161","LU0417516738.SGD","LU2399975544.HKD","LU0417516902.SGD","IE00B543WZ88.USD","LU0417516571.SGD","LU0348784397.USD","KURE","LU1720050803.USD","LU2778985437.USD","FCA","LU0348827113.USD","09926","LU2476274308.USD","LU0348735423.USD","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0540923850.HKD","LU0348767384.USD","LU0634319403.HKD","BK1574","LU0348825331.USD","LU0348783233.USD","LU2488822045.USD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662378920","title":"Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2662378920","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662378920?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870742,"startTime":"0","endTime":"0","summary":"It's been a good week for Innovent Biologics, Inc. ( HKG:1801 ) shareholders, because the company has just released its...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/earnings-beat-innovent-biologics-inc-just-beat-analyst-forec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/earnings-beat-innovent-biologics-inc-just-beat-analyst-forec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","VGFPF","BK1589","LU0463099449.HKD","BK1161","LU2097828631.EUR","FEBU","GXDW","LU0326950275.SGD","01801","PMDE","LU1188198961.HKD","LU2097828805.USD","LU2242644610.SGD","RGLO","LU0455707207.USD","LU2097828557.USD","LU2328871848.SGD","HK0000165453.HKD","DECU","LU2097828714.EUR","LU0502904849.HKD","KURE","LU1969619763.USD","JOYT","LU2488822045.USD","VOTE","LU0244354667.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086799","title":"Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662086799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:51","pubTimestamp":1787842274,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day disclosure return, issues 182,021 new sharesInnovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.Issued 182,021","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL82CCyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","LU0463099449.HKD","LU1188198961.HKD","LU2097828805.USD","01801","LU0244354667.USD","LU2488822045.USD","LU2097828557.USD","LU0455707207.USD","LU2097828631.EUR","BK1161","LU1969619763.USD","LU0326950275.SGD","LU2328871848.SGD","HK0000165453.HKD","BK1147","BK1589","LU2097828714.EUR","LU0502904849.HKD","KURE","LU2097828474.EUR","LU2242644610.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790083","title":"Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790083","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:00","pubTimestamp":1787839249,"startTime":"0","endTime":"0","summary":"Akeso FY26 H1 net loss narrows 23.98% to RMB 447.2 million; revenue rises 27.92% to RMB 1.81 billionAkeso posted revenue of RMB 1.81 billion, up 27.92% year over year, driven mainly by cadonilimab and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL34jFkn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU1961090484.USD","LU2476274720.SGD","LU0348783233.USD","LU1720050803.USD","LU0348784397.USD","LU0348735423.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348766576.USD","LU0417516738.SGD","KURE","LU0348825331.USD","LU2399975544.HKD","BK1574","LU2488822045.USD","BK1161","LU0540923850.HKD","LU0348767384.USD","LU2778985437.USD","LU0348827113.USD","LU0634319403.HKD","LU0417516902.SGD","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}